Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Primary Care
What is your approach to a patient with rheumatoid arthritis and moderate disease activity on 25 mg of PO methotrexate?
Do you switch to SQ MTX, or is it best to add tx, such as a TNFi?
Answer from: at Community Practice
Switching to sub cu may work for low disease activity, but not moderate.
Sign in or Register to read more
10978
Related Questions
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
How do you approach treatment selection in patients with rheumatoid arthritis and severe COPD?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How would you manage a patient with progressive/refractory molluscum contagiosum who is well controlled on methotrexate for seropositive rheumatoid arthritis?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?